Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.45 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | FDPS | P14324 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.43 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1282988 | 1.00 | CA2 (0.52) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL129992 | 1.00 | CA2 (0.52) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL6051331 | 0.95 | CA2 (0.48) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL11747663 | 0.92 | CA2 (0.45) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL1507416 | 0.91 | CA2 (0.45) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL10496961 | 0.90 | CA2 (0.48) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL5933413 | 0.90 | CA2 (0.48) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL15674875 | 0.90 | CA2 (0.48) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL10995430 | 0.90 | CA2 (0.48) | CA2LMNAGRIK1GRIK2GPR84 | |
| SCHEMBL10992388 | 0.89 | CA2 (0.44) | CA2LMNAGRIK1GRIK2GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10233402-B2 | Pressure medium oil and method for using said pressure medium oil | IDEMITSU KOSAN CO., LTD. (JP) | 2019-03-19 | — | — | US | disclosed |
| US-20170283730-A1 | PRESSURE MEDIUM OIL AND METHOD FOR USING SAID PRESSURE MEDIUM OIL | IDEMITSU KOSAN CO., LTD. (JP) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283730-A1 | PRESSURE MEDIUM OIL AND METHOD FOR USING SAID PRESSURE MEDIUM OIL | GRN, NUP160, MYB | CA2 3296/4885LMNA 816/4885GRIK1 1410/4885 |
| US-10233402-B2 | Pressure medium oil and method for using said pressure medium oil | GRN, NUP160, MYB | CA2 3296/4885LMNA 816/4885GRIK1 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.